Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A. Torres, J. Serra, A. Ferrer, P. Jiménez, R. De Celis, E. Cobo, et al.
Severe community-acquired pneumonia: epidemiology and prognostic factors.
Am Rev Respir Dis, 144 (1991), pp. 312-318
[2.]
R. Austrian.
Pneumococcal bacteriemia with special reference to bacteriemic pneumococcal pneumonia.
Ann Intern Med, 6 (1964), pp. 759-770
[3.]
Y. Sibille, H.Y. Reynolds.
Macrophages and polymorphonuclear neutrophils in lung defense and injury.
Am Rev Respir Dis, 141 (1990), pp. 471-501
[4.]
S. Nelson, G.J. Bagby, B.G. Bainton, L.A. Wilson, J.J. Thompson, W.R. Summer.
Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.
J Infect Dis, 159 (1989), pp. 189-194
[6.]
M. Dehoux, A. Boutten, J. Ostinelli, N. Seta, M.C. Dombret, B. Crestani, et al.
Compartmentalised cytokine production within the human lung in unilateral pneumonia.
Am J Respir Crit Care Med, 150 (1994), pp. 710-716
[7.]
C. Montón, A. Torres, M. El-Ebiary, X. Filella, A. Xaubet, J. Puig de la Bellacasa.
Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Crit Care Med, 27 (1999), pp. 1745-1753
[8.]
C. Martín, P. Saux, J.L. Mege, G. Perrin, L. Papazian, F. Gonin.
Prognostic value of serum cytokines in septic shock.
Intensive Care Med, 20 (1994), pp. 272-277
[10.]
T.R. Martin.
Cytokines and the acute respiratory distress syndrome: a question of balance.
Nat Med, 3 (1997), pp. 272-273
[11.]
P. Glynn, R. Coakley, I. Kilgallen, N. Murphy, S. O'Neill.
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia.
Thorax, 54 (1999), pp. 51-55
[12.]
R. Lefering, E.A.M. Neugebauer.
Steroid controversy in sepsis and septic shock: a meta-analysis.
Crit Care Med, 23 (1995), pp. 1294-1303
[13.]
R.P. Schleimer.
An overview of glucocorticoid anti-inflammatory actions.
Eur J Clin Pharmacol, 45 (1993), pp. 3-7
[14.]
J. Mullol, L. Pujols, C. Picado.
Mecanismos de acción de los glucocorticoides. Aplicación al tratamiento de la inflamación respiratoria.
Arch Bronconeumol, 32 (1996), pp. 527-534
[15.]
L. Cronin, D.J. Cook, J. Carlet, D.K. Heyland, D. King, M.A. Lausang, et al.
Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.
Crit Care Med, 23 (1995), pp. 1430-1439
[16.]
M.T. Labro.
Anti-inflammatory activity of macrolides: a new therapeutic potential?.
J Antimicrob Chemother, 41 (1998), pp. 37-46
[17.]
C. Odio, I. Faingezicht, M. Paris.
The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.
N Engl J Med, 324 (1991), pp. 1525-1531
[18.]
C.N. Mock, G.J. Jurkovich, D.J. Dries, R.V. Maier.
Clinical significance of antibiotic endotoxin-releasing properties in trauma patients.
Arch Sur, 130 (1995), pp. 1234-1241
[19.]
A.E. Barber, S.M. Coyle, M.A. Marano, E. Fischer, S.E. Calvano, Y. Fong, et al.
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man.
J Immunol, 150 (1993), pp. 1999-2006
[20.]
C. Montón, S. Ewig, A. Torres, M. El-Ebiary, X. Filella, A. Rañó, et al.
Role of glucocorticoids on inflammatory response in non-immunocompromised patients with pneumonia: a pilot study.
Eur Respir J, 14 (1999), pp. 218-220
[21.]
C. Agustí, A. Rañó, X. Filella, J. González, A. Moreno, A. Xaubet, et al.
Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment.
Chest, 123 (2003), pp. 488-498
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
